Orifarm ramps up growth plans following USD 703m acquisition
![Erik Sandberg, CEO of Orifarm | Photo: PR /Orifarm](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13744343.ece/ALTERNATES/schema-16_9/doc7jrc066v1oha377f2nr.jpg)
A historical acquisition for no less than DKK 4.6bn (USD 703m) was the beginning of a growth journey for Danish pharmaceutical firm Orifarm – but the adventure is far from over.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Takeda's new CEO in Denmark wants to hire more people
For subscribers
Lundbeck preps for war against generic drugmakers in US
For subscribers